New liquid biopsy test to ID lymph node metastasis in early-stage T1 colorectal cancer
This new, blood-based test successfully identifies individuals with lymph node metastasis associated with high-risk T1 colorectal cancer and potentially could help people with non-high-risk early-stage colorectal cancer avoid unnecessary colon surgery
Published 2021-04-21 · Original archive entry · Explore research explainers
DUARTE, Calif. -- Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma. Research on the development of the blood test was reported in a END